Michael Kalb
Director Financiero/CFO en CATALYST PHARMACEUTICALS, INC. .
Cargos activos de Michael Kalb
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CATALYST PHARMACEUTICALS, INC. | Director Financiero/CFO | 01/01/2024 | - |
Historial de carrera de Michael Kalb
Antiguos cargos conocidos de Michael Kalb.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| IPI LEGACY LIQUIDATION CO | Director Financiero/CFO | 10/05/2023 | 31/12/2023 |
| CINCOR PHARMA, INC. | Comptroller/Controller/Auditor | 04/11/2022 | 01/03/2023 |
| Director Financiero/CFO | 04/11/2022 | 01/03/2023 | |
| AMARIN CORPORATION PLC | Director Financiero/CFO | 30/06/2016 | 20/06/2022 |
| TARO PHARMACEUTICAL INDUSTRIES LTD. | Comptroller/Controller/Auditor | 15/11/2010 | 29/06/2016 |
| Director Financiero/CFO | 22/11/2010 | 29/06/2016 | |
| HURON CONSULTING GROUP INC. | Comptroller/Controller/Auditor | - | - |
Taro Pharmaceuticals U.S.A., Inc.
 Taro Pharmaceuticals U.S.A., Inc. Pharmaceuticals: GenericHealth Technology Part of Sun Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. is a company that manufactures and sells generic pharmaceutical products. The company is based in Hawthorne, NY. | Director Financiero/CFO | 01/06/2009 | - |
Formación de Michael Kalb.
| State University of New York at Albany | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
| Israel | 2 |
| Irlanda | 2 |
Operativa
| Director of Finance/CFO | 6 |
| Comptroller/Controller/Auditor | 3 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 7 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 5 |
|---|---|
| TARO PHARMACEUTICAL INDUSTRIES LTD. | Health Technology |
| AMARIN CORPORATION PLC | Health Technology |
| HURON CONSULTING GROUP INC. | Commercial Services |
| IPI LEGACY LIQUIDATION CO | Health Technology |
| CATALYST PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Taro Pharmaceuticals U.S.A., Inc.
Taro Pharmaceuticals U.S.A., Inc. Pharmaceuticals: GenericHealth Technology Part of Sun Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc. is a company that manufactures and sells generic pharmaceutical products. The company is based in Hawthorne, NY. | Health Technology |
CinCor Pharma, Inc.
 CinCor Pharma, Inc. Pharmaceuticals: MajorHealth Technology CinCor Pharma, Inc. operates as a clinical-stage biopharmaceutical company focused on developing its clinical candidate, CIN-107, for the treatment of hypertension and other cardio-renal diseases. The firm is developing CIN-107 for the treatment of multiple diseases where aldosterone plays a significant role in disease pathophysiology, including hypertension and primary aldosteronism, as well as its utility in ameliorating complications of chronic kidney disease. The company was founded by Jon Isaacsohn and Catherine Pearce on March 28, 2018 and is headquartered in Waltham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Kalb
- Experiencia
